OliX Pharmaceuticals, Inc. (226950) Price & Analysis

― Followers

226950 Stock Chart & Stats

₩98100.00

-₩11,300.00(-10.33%)

Aug 21, 2026

―

Day’s Range― - ―

52-Week Range₩51,750.00 - ₩217,000.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)327.41K

Market Cap

₩2.07T

Enterprise Value₩3.28M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.09

Next Earnings

Nov 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-492.64

Shares Outstanding21,062,850

10 Day Avg. Volume265,961

30 Day Avg. Volume327,412

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

226950 FAQ

What was OliX Pharmaceuticals, Inc.’s price range in the past 12 months?

OliX Pharmaceuticals, Inc. lowest stock price was ₩51750.00 and its highest was ₩217000.00 in the past 12 months.

What is OliX Pharmaceuticals, Inc.’s market cap?

OliX Pharmaceuticals, Inc.’s market cap is ₩2.07T.

When is OliX Pharmaceuticals, Inc.’s upcoming earnings report date?

OliX Pharmaceuticals, Inc.’s upcoming earnings report date is Nov 13, 2026 which is in 81 days.

How were OliX Pharmaceuticals, Inc.’s earnings last quarter?

OliX Pharmaceuticals, Inc. released its earnings results on Aug 14, 2026. The company reported -₩492.64 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is OliX Pharmaceuticals, Inc. overvalued?

According to Wall Street analysts OliX Pharmaceuticals, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does OliX Pharmaceuticals, Inc. pay dividends?

OliX Pharmaceuticals, Inc. does not currently pay dividends.

What is OliX Pharmaceuticals, Inc.’s EPS estimate?

OliX Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does OliX Pharmaceuticals, Inc. have?

OliX Pharmaceuticals, Inc. has 21,062,850 shares outstanding.

What happened to OliX Pharmaceuticals, Inc.’s price movement after its last earnings report?

OliX Pharmaceuticals, Inc. reported an EPS of -₩492.64 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.444%.

Which hedge fund is a major shareholder of OliX Pharmaceuticals, Inc.?

Currently, no hedge funds are holding shares in KR:226950

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology